Previous 10 | Next 10 |
Twist Bioscience Corporation (TWST) Q3 2019 Results Earnings Conference Call August 01, 2019, 04:30 PM ET Company Participants Jim Thorburn - Chief Financial Officer Emily Leproust - CEO and Cofounder of Twist Conference Call Participants Doug Schenkel - Cowen Catherine Sch...
Twist Bioscience (NASDAQ: TWST ): Q3 GAAP EPS of -$0.92 misses by $0.11 . More news on: Twist Bioscience Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...
-- Revenues Increase 108% over Third Quarter 2018 -- -- Increasing Fiscal 2019 Revenue Guidance to $52 to $53 Million; Adjusting Net Loss Guidance to $102 to $104 Million to Reflect Acceleration of Commercial Organization -- -- Continued Strength in Synthetic Biology and NGS Businesses...
Synthetic DNA producer Twist Bioscience ( TWST +4.9% ) is up on below-average volume in reaction its the launch of long oligonucleotides, up to 300 bases, that it says is the longest commercial "oligo" made by continuous chemical synthesis. More news on: Twist Bioscience Corporation,...
-- Oligonucleotides up to 300 Bases with Exceptionally Low Error Rate – -- Longest Commercial Oligonucleotide Offering Available Today -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA...
-- Agreement Enables Twist to Securely Store DNA With Digital Data Encoded -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has entered into an ag...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that it will issue its financial results for the fiscal 2019 third quarter ended June 30, 2019, following the close of market on Thursday, A...
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (y...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , iTunes...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of the Twist Mouse Core Exome Panel, the most comprehensive, up-to-date tool for interrogation of the...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...